The Latest Cardiac and Vascular News
DANVERS, Mass., June 30, 2017 (GLOBE NEWSWIRE) — Abiomed, Inc. (NASDAQ:ABMD), a leading provider of breakthrough heart support and recovery technologies, announced today the recent publication of a peer-reviewed retrospective study on hemodynamic support with the Impella 2.5® heart pump. The study […]
WASHINGTON, June 09, 2017 (GLOBE NEWSWIRE) — Nineteen patients who benefitted from treatment with Abiomed’s Impella heart pumps traveled to Washington, D.C. on June 8, 2017, to meet with elected officials and participate in a Congressional Briefing hosted by the […]
DANVERS, Mass., May 09, 2017 (GLOBE NEWSWIRE) — Abiomed, Inc. (NASDAQ:ABMD), a leading provider of breakthrough heart support and recovery technologies, announced the debut of the 3rd Generation Impella CP heart pump at the Annual meeting of the Society for […]
Abiomed Marks Grand Opening of Newly-Expanded Headquarters in Danvers, Massachusetts – Governor Baker joins heart recovery leader for grand opening of new manufacturing and training space that represents major investment in Massachusetts DANVERS, Mass., March 30, 2017 (GLOBE NEWSWIRE) — […]
DANVERS, Mass., March 09, 2017 (GLOBE NEWSWIRE) — A new study published in Circulation Research finds use of hemodynamic support with Impella® 2.5 heart pump during high-risk percutaneous coronary intervention (HRPCI) can reduce the risk of acute kidney injury (AKI) […]
